Skip to main content
Top
Published in: Respiratory Research 1/2012

Open Access 01-12-2012 | Research

Detection of Pseudomonas aeruginosa in sputum headspace through volatile organic compound analysis

Authors: Pieter C Goeminne, Thomas Vandendriessche, Johan Van Eldere, Bart M Nicolai, Maarten LATM Hertog, Lieven J Dupont

Published in: Respiratory Research | Issue 1/2012

Login to get access

Abstract

Introduction

Chronic pulmonary infection is the hallmark of Cystic Fibrosis lung disease. Searching for faster and easier screening may lead to faster diagnosis and treatment of Pseudomonas aeruginosa (P. aeruginosa). Our aim was to analyze and build a model to predict the presence of P. aeruginosa in sputa.

Methods

Sputa from 28 bronchiectatic patients were used for bacterial culturing and analysis of volatile compounds by gas chromatography–mass spectrometry. Data analysis and model building were done by Partial Least Squares Regression Discriminant analysis (PLS-DA). Two analysis were performed: one comparing P. aeruginosa positive with negative cultures at study visit (PA model) and one comparing chronic colonization according to the Leeds criteria with P. aeruginosa negative patients (PACC model).

Results

The PA model prediction of P. aeruginosa presence was rather poor, with a high number of false positives and false negatives. On the other hand, the PACC model was stable and explained chronic P. aeruginosa presence for 95% with 4 PLS-DA factors, with a sensitivity of 100%, a positive predictive value of 86% and a negative predictive value of 100%.

Conclusion

Our study shows the potential for building a prediction model for the presence of chronic P. aeruginosa based on volatiles from sputum.
Appendix
Available only for authorised users
Literature
1.
go back to reference Konstan MW, Morgan WJ, Butler SM, Pasta DJ, Craib ML, Silva SJ, Stokes DC, Wohl ME, Wagener JS, Regelmann WE, Johnson CA: Scientific advisory group and the investigators and coordinators of the epidemiologic study of cystic fibrosis. Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis. J Pediatr. 2007, 151: 134-139. 10.1016/j.jpeds.2007.03.006.PubMedCrossRef Konstan MW, Morgan WJ, Butler SM, Pasta DJ, Craib ML, Silva SJ, Stokes DC, Wohl ME, Wagener JS, Regelmann WE, Johnson CA: Scientific advisory group and the investigators and coordinators of the epidemiologic study of cystic fibrosis. Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis. J Pediatr. 2007, 151: 134-139. 10.1016/j.jpeds.2007.03.006.PubMedCrossRef
2.
go back to reference McPhail GL, Acton JD, Fenchel MC, Amin RS, Seid M: Improvements in lung function outcomes in children with cystic fibrosis are associated with better nutrition, fewer chronic pseudomonas aeruginosa infections, and dornase alfa use. J Pediatr. 2008, 153: 752-757. 10.1016/j.jpeds.2008.07.011.PubMedCrossRef McPhail GL, Acton JD, Fenchel MC, Amin RS, Seid M: Improvements in lung function outcomes in children with cystic fibrosis are associated with better nutrition, fewer chronic pseudomonas aeruginosa infections, and dornase alfa use. J Pediatr. 2008, 153: 752-757. 10.1016/j.jpeds.2008.07.011.PubMedCrossRef
3.
go back to reference Kerem E, Corey M, Gold R, Levison H: Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa. J Pediatr. 1990, 116: 714-719. 10.1016/S0022-3476(05)82653-8.PubMedCrossRef Kerem E, Corey M, Gold R, Levison H: Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa. J Pediatr. 1990, 116: 714-719. 10.1016/S0022-3476(05)82653-8.PubMedCrossRef
4.
go back to reference Emerson J, Rosenfeld M, McNamara S, Ramsey B, Gibson RL: Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol. 2002, 34: 91-100. 10.1002/ppul.10127.PubMedCrossRef Emerson J, Rosenfeld M, McNamara S, Ramsey B, Gibson RL: Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol. 2002, 34: 91-100. 10.1002/ppul.10127.PubMedCrossRef
5.
go back to reference Kozlowska WJ, Bush A, Wade A, Aurora P, Carr SB, Castle RA, Hoo AF, Lum S, Price J, Ranganathan S, Saunders C, Stanojevic S, Stroobant J, Wallis C, Stocks J: London cystic fibrosis collaboration. Lung function from infancy to the preschool years after clinical diagnosis of cystic fibrosis. Am J Respir Crit Care Med. 2008, 178: 42-49. 10.1164/rccm.200710-1599OC.PubMedCrossRef Kozlowska WJ, Bush A, Wade A, Aurora P, Carr SB, Castle RA, Hoo AF, Lum S, Price J, Ranganathan S, Saunders C, Stanojevic S, Stroobant J, Wallis C, Stocks J: London cystic fibrosis collaboration. Lung function from infancy to the preschool years after clinical diagnosis of cystic fibrosis. Am J Respir Crit Care Med. 2008, 178: 42-49. 10.1164/rccm.200710-1599OC.PubMedCrossRef
6.
go back to reference Pamukcu A, Bush A, Buchdahl R: Effects of pseudomonas aeruginosa colonization on lung function and anthropometric variables in children with cystic fibrosis. Pediatr Pulmonol. 1995, 19: 10-15.PubMedCrossRef Pamukcu A, Bush A, Buchdahl R: Effects of pseudomonas aeruginosa colonization on lung function and anthropometric variables in children with cystic fibrosis. Pediatr Pulmonol. 1995, 19: 10-15.PubMedCrossRef
7.
go back to reference Kosorok MR, Zeng L, West SE, Rock MJ, Splaingard ML, Laxova A, Green CG, Collins J, Farrell PM: Acceleration of lung disease in children with cystic fibrosis after pseudomonas aeruginosa acquisition. Pediatr Pulmonol. 2001, 32: 277-287. 10.1002/ppul.2009.abs.PubMedCrossRef Kosorok MR, Zeng L, West SE, Rock MJ, Splaingard ML, Laxova A, Green CG, Collins J, Farrell PM: Acceleration of lung disease in children with cystic fibrosis after pseudomonas aeruginosa acquisition. Pediatr Pulmonol. 2001, 32: 277-287. 10.1002/ppul.2009.abs.PubMedCrossRef
8.
go back to reference Henry RL, Mellis CM, Petrovic L: Mucoid pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis. Pediatr Pulmonol. 1992, 12: 158-161. 10.1002/ppul.1950120306.PubMedCrossRef Henry RL, Mellis CM, Petrovic L: Mucoid pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis. Pediatr Pulmonol. 1992, 12: 158-161. 10.1002/ppul.1950120306.PubMedCrossRef
9.
go back to reference Courtney JM, Bradley J, Mccaughan J, O’Connor TM, Shortt C, Bredin CP, Bradbury I, Elborn JS: Predictors of mortality in adults with cystic fibrosis. Pediatr Pulmonol. 2007, 42: 525-532. 10.1002/ppul.20619.PubMedCrossRef Courtney JM, Bradley J, Mccaughan J, O’Connor TM, Shortt C, Bredin CP, Bradbury I, Elborn JS: Predictors of mortality in adults with cystic fibrosis. Pediatr Pulmonol. 2007, 42: 525-532. 10.1002/ppul.20619.PubMedCrossRef
10.
go back to reference Burns JL, Gibson RL, McNamara S, Yim D, Emerson J, Rosenfeld M, Hiatt P, McCoy K, Castile R, Smith AL, Ramsey BW: Longitudinal assessment of pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis. 2001, 183: 444-452. 10.1086/318075.PubMedCrossRef Burns JL, Gibson RL, McNamara S, Yim D, Emerson J, Rosenfeld M, Hiatt P, McCoy K, Castile R, Smith AL, Ramsey BW: Longitudinal assessment of pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis. 2001, 183: 444-452. 10.1086/318075.PubMedCrossRef
11.
go back to reference Hansen CR, Pressler T, Hoiby N: Early aggressive eradication therapy for intermittent pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience. J Cyst Fibros. 2008, 7: 523-530. 10.1016/j.jcf.2008.06.009.PubMedCrossRef Hansen CR, Pressler T, Hoiby N: Early aggressive eradication therapy for intermittent pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience. J Cyst Fibros. 2008, 7: 523-530. 10.1016/j.jcf.2008.06.009.PubMedCrossRef
12.
go back to reference Armstrong DS, Grimwood K, Carlin JB, Carzino R, Olinsky A, Phelan PD: Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis. Pediatr Pulmonol. 1996, 21: 267-275. 10.1002/(SICI)1099-0496(199605)21:5<267::AID-PPUL1>3.0.CO;2-K.PubMedCrossRef Armstrong DS, Grimwood K, Carlin JB, Carzino R, Olinsky A, Phelan PD: Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis. Pediatr Pulmonol. 1996, 21: 267-275. 10.1002/(SICI)1099-0496(199605)21:5<267::AID-PPUL1>3.0.CO;2-K.PubMedCrossRef
13.
go back to reference Endeman H, Schelfhout V, Voorn GP, van Velzen-Blad H, Grutters JC, Biesma DH: Clinical features predicting failure of pathogen identification in patients with community acquired pneumonia. Scand J Infect Dis. 2008, 40: 715-720. 10.1080/00365540802014864.PubMedCrossRef Endeman H, Schelfhout V, Voorn GP, van Velzen-Blad H, Grutters JC, Biesma DH: Clinical features predicting failure of pathogen identification in patients with community acquired pneumonia. Scand J Infect Dis. 2008, 40: 715-720. 10.1080/00365540802014864.PubMedCrossRef
14.
go back to reference Terpstra WJ, Schoone GJ, Ter SJ, van Nierop JC, Griffioen RW: In situ hybridization for the detection of haemophilus in sputum of patients with cystic fibrosis. Scand J Infect Dis. 1987, 19: 641-646. 10.3109/00365548709117199.PubMedCrossRef Terpstra WJ, Schoone GJ, Ter SJ, van Nierop JC, Griffioen RW: In situ hybridization for the detection of haemophilus in sputum of patients with cystic fibrosis. Scand J Infect Dis. 1987, 19: 641-646. 10.3109/00365548709117199.PubMedCrossRef
15.
go back to reference Verenkar MP, Pinto MJ, Savio R, Virginkar N, Singh I: Bacterial pneumonias–evaluation of various sputum culture methods. J Postgrad Med. 1993, 39: 60-62.PubMed Verenkar MP, Pinto MJ, Savio R, Virginkar N, Singh I: Bacterial pneumonias–evaluation of various sputum culture methods. J Postgrad Med. 1993, 39: 60-62.PubMed
16.
go back to reference Pressler T, Bohmova C, Conway S, Dumcius S, Hjelte L, Høiby N, Kollberg H, Tümmler B, Vavrova V: Chronic pseudomonas aeruginosa infection definition: EuroCareCF working group report. J Cyst Fibros. 2011, 10: S75-S78.PubMedCrossRef Pressler T, Bohmova C, Conway S, Dumcius S, Hjelte L, Høiby N, Kollberg H, Tümmler B, Vavrova V: Chronic pseudomonas aeruginosa infection definition: EuroCareCF working group report. J Cyst Fibros. 2011, 10: S75-S78.PubMedCrossRef
17.
go back to reference Pasteur MC, Bilton D, Hill AT: British Thoracic Society guideline for non-CF bronchiectasis. Thorax. 2010, 65: i1-i58. 10.1136/thx.2010.136119.PubMedCrossRef Pasteur MC, Bilton D, Hill AT: British Thoracic Society guideline for non-CF bronchiectasis. Thorax. 2010, 65: i1-i58. 10.1136/thx.2010.136119.PubMedCrossRef
18.
go back to reference Enderby B, Smith D, Carroll W, Lenney W: Hydrogen cyanide as a biomarker for Pseudomonas aeruginosa in the breath of children with cystic fibrosis. Pediatr Pulmonol. 2009, 44: 142-147. 10.1002/ppul.20963.PubMedCrossRef Enderby B, Smith D, Carroll W, Lenney W: Hydrogen cyanide as a biomarker for Pseudomonas aeruginosa in the breath of children with cystic fibrosis. Pediatr Pulmonol. 2009, 44: 142-147. 10.1002/ppul.20963.PubMedCrossRef
19.
go back to reference Robroeks CM, van Berkel JJ, Dallinga JW, Jöbsis Q, Zimmerman LJ, Hendriks HJ, Wouters MF, van der Grinten CP, van de Kant KD, van Schooten FJ, Dompeling E: Metabolomics of volatile organic compounds in cystic fibrosis patients and controls. Pediatr Res. 2010, 68: 75-80. 10.1203/PDR.0b013e3181df4ea0.PubMedCrossRef Robroeks CM, van Berkel JJ, Dallinga JW, Jöbsis Q, Zimmerman LJ, Hendriks HJ, Wouters MF, van der Grinten CP, van de Kant KD, van Schooten FJ, Dompeling E: Metabolomics of volatile organic compounds in cystic fibrosis patients and controls. Pediatr Res. 2010, 68: 75-80. 10.1203/PDR.0b013e3181df4ea0.PubMedCrossRef
20.
go back to reference Shestivska V, Nemec A, Dřevínek P, Sovová K, Dryahina K, Spaněl P: Quantification of methyl thiocyanate in the headspace of pseudomonas aeruginosa cultures and in the breath of cystic fibrosis patients by selected ion flow tube mass spectrometry. Rapid Commun Mass Spectrom. 2011, 25: 2459-2467. 10.1002/rcm.5146.PubMedCrossRef Shestivska V, Nemec A, Dřevínek P, Sovová K, Dryahina K, Spaněl P: Quantification of methyl thiocyanate in the headspace of pseudomonas aeruginosa cultures and in the breath of cystic fibrosis patients by selected ion flow tube mass spectrometry. Rapid Commun Mass Spectrom. 2011, 25: 2459-2467. 10.1002/rcm.5146.PubMedCrossRef
21.
go back to reference Allardyce RA, Langford VS, Hill AL, Murdoch DR: Detection of volatile metabolites produced by bacterial growth in blood culture media by selected ion flow tube mass spectrometry (SIFT-MS). J Microbiol Methods. 2006, 65: 361-365. 10.1016/j.mimet.2005.09.003.PubMedCrossRef Allardyce RA, Langford VS, Hill AL, Murdoch DR: Detection of volatile metabolites produced by bacterial growth in blood culture media by selected ion flow tube mass spectrometry (SIFT-MS). J Microbiol Methods. 2006, 65: 361-365. 10.1016/j.mimet.2005.09.003.PubMedCrossRef
22.
go back to reference Carroll W, Lenney W, Wang T, Spanel P, Alcock A, Smith D: Detection of volatile compounds emitted by pseudomonas aeruginosa using selected ion flow tube mass spectrometry. Pediatr Pulmonol. 2005, 39: 452-456. 10.1002/ppul.20170.PubMedCrossRef Carroll W, Lenney W, Wang T, Spanel P, Alcock A, Smith D: Detection of volatile compounds emitted by pseudomonas aeruginosa using selected ion flow tube mass spectrometry. Pediatr Pulmonol. 2005, 39: 452-456. 10.1002/ppul.20170.PubMedCrossRef
23.
go back to reference Gilchrist FJ, Alcock A, Belcher J, Brady M, Jones A, Smith D, Spaněl P, Webb K, Lenney W: Variation in hydrogen cyanide production between different strains of pseudomonas aeruginosa. Eur Respir J. 2011, 38: 409-414. 10.1183/09031936.00166510.PubMedCrossRef Gilchrist FJ, Alcock A, Belcher J, Brady M, Jones A, Smith D, Spaněl P, Webb K, Lenney W: Variation in hydrogen cyanide production between different strains of pseudomonas aeruginosa. Eur Respir J. 2011, 38: 409-414. 10.1183/09031936.00166510.PubMedCrossRef
24.
go back to reference Thorn RM, Reynolds DM, Greenman J: Multivariate analysis of bacterial volatile compound profiles for discrimination between selected species and strains in vitro. J Microbiol Methods. 2011, 84: 258-264. 10.1016/j.mimet.2010.12.001.PubMedCrossRef Thorn RM, Reynolds DM, Greenman J: Multivariate analysis of bacterial volatile compound profiles for discrimination between selected species and strains in vitro. J Microbiol Methods. 2011, 84: 258-264. 10.1016/j.mimet.2010.12.001.PubMedCrossRef
25.
go back to reference Zhu J, Bean HD, Kuo YM, Hill JE: Fast detection of volatile organic compounds from bacterial cultures by secondary electrospray ionization-mass spectrometry. J Clin Microbiol. 2010, 48: 4426-4431. 10.1128/JCM.00392-10.PubMedPubMedCentralCrossRef Zhu J, Bean HD, Kuo YM, Hill JE: Fast detection of volatile organic compounds from bacterial cultures by secondary electrospray ionization-mass spectrometry. J Clin Microbiol. 2010, 48: 4426-4431. 10.1128/JCM.00392-10.PubMedPubMedCentralCrossRef
26.
go back to reference Zechman JM, Labows JN: Volatiles of Pseudomonas aeruginosa and related species by automated headspace concentration–gas chromatography. Can J Microbiol. 1985, 31: 232-237. 10.1139/m85-045.PubMedCrossRef Zechman JM, Labows JN: Volatiles of Pseudomonas aeruginosa and related species by automated headspace concentration–gas chromatography. Can J Microbiol. 1985, 31: 232-237. 10.1139/m85-045.PubMedCrossRef
27.
go back to reference Cox CD, Parker J: Use of 2-aminoacetophenone production in identification of pseudomonas aeruginosa. J Clin Microbiol. 1979, 9: 479-484.PubMedPubMedCentral Cox CD, Parker J: Use of 2-aminoacetophenone production in identification of pseudomonas aeruginosa. J Clin Microbiol. 1979, 9: 479-484.PubMedPubMedCentral
28.
go back to reference Labows JN, McGinley KJ, Webster GF, Leyden JJ: Headspace analysis of volatile metabolites of pseudomonas aeruginosa and related species by gas chromatography–mass spectrometry. J Clin Microbiol. 1980, 12: 521-526.PubMedPubMedCentral Labows JN, McGinley KJ, Webster GF, Leyden JJ: Headspace analysis of volatile metabolites of pseudomonas aeruginosa and related species by gas chromatography–mass spectrometry. J Clin Microbiol. 1980, 12: 521-526.PubMedPubMedCentral
29.
go back to reference Wang T, Carroll W, Lenny W, Boit P, Smith D: The analysis of 1-propanol and 2-propanol in humid air samples using selected ion flow tube mass spectrometry. Rapid Commun Mass Spectrom. 2006, 20: 125-130. 10.1002/rcm.2285.PubMedCrossRef Wang T, Carroll W, Lenny W, Boit P, Smith D: The analysis of 1-propanol and 2-propanol in humid air samples using selected ion flow tube mass spectrometry. Rapid Commun Mass Spectrom. 2006, 20: 125-130. 10.1002/rcm.2285.PubMedCrossRef
30.
go back to reference Preti G, Thaler E, Hanson CW, Troy M, Eades J, Gelperin A: Volatile compounds characteristic of sinus-related bacteria and infected sinus mucus: analysis by solid-phase microextraction and gas chromatography–mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2009, 877: 2011-2018. 10.1016/j.jchromb.2009.05.028.PubMedCrossRef Preti G, Thaler E, Hanson CW, Troy M, Eades J, Gelperin A: Volatile compounds characteristic of sinus-related bacteria and infected sinus mucus: analysis by solid-phase microextraction and gas chromatography–mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2009, 877: 2011-2018. 10.1016/j.jchromb.2009.05.028.PubMedCrossRef
31.
go back to reference Savelev SU, Perry JD, Bourke SJ, Jary H, Taylor R, Fisher AJ, Corris PA, Petrie M, De Soyza A: Volatile biomarkers of pseudomonas aeruginosa in cystic fibrosis and noncystic fibrosis bronchiectasis. Lett Appl Microbiol. 2011, 52: 610-613. 10.1111/j.1472-765X.2011.03049.x.PubMedCrossRef Savelev SU, Perry JD, Bourke SJ, Jary H, Taylor R, Fisher AJ, Corris PA, Petrie M, De Soyza A: Volatile biomarkers of pseudomonas aeruginosa in cystic fibrosis and noncystic fibrosis bronchiectasis. Lett Appl Microbiol. 2011, 52: 610-613. 10.1111/j.1472-765X.2011.03049.x.PubMedCrossRef
32.
go back to reference Lee TW, Brownlee KG, Conway SP, Denton M, Littlewood JM: Evaluation of a new definition for chronic pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros. 2003, 2: 29-34. 10.1016/S1569-1993(02)00141-8.PubMedCrossRef Lee TW, Brownlee KG, Conway SP, Denton M, Littlewood JM: Evaluation of a new definition for chronic pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros. 2003, 2: 29-34. 10.1016/S1569-1993(02)00141-8.PubMedCrossRef
33.
go back to reference Vandendool H, Kratz PD: A generalization of the retention index system including linear temperature programmed gas-liquide partition chromatography. J Chromatogr. 1963, 11: 463-471.PubMedCrossRef Vandendool H, Kratz PD: A generalization of the retention index system including linear temperature programmed gas-liquide partition chromatography. J Chromatogr. 1963, 11: 463-471.PubMedCrossRef
34.
go back to reference Ooms K: Identification of potentially causal regressors in PLS models. 1996, Dissertation: International Study Program in Statistics. KUL Ooms K: Identification of potentially causal regressors in PLS models. 1996, Dissertation: International Study Program in Statistics. KUL
35.
go back to reference Horvath I, Hunt J, Barnes PJ, et al: Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J. 2005, 26: 523-548. 10.1183/09031936.05.00029705.PubMedCrossRef Horvath I, Hunt J, Barnes PJ, et al: Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J. 2005, 26: 523-548. 10.1183/09031936.05.00029705.PubMedCrossRef
36.
go back to reference Westhoff M, Litterst P, Freitag L, Urfer W, Bader S, Baumbach JI: Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study. Thorax. 2009, 64: 744-748. 10.1136/thx.2008.099465.PubMedCrossRef Westhoff M, Litterst P, Freitag L, Urfer W, Bader S, Baumbach JI: Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study. Thorax. 2009, 64: 744-748. 10.1136/thx.2008.099465.PubMedCrossRef
37.
go back to reference Buszewski B, Kesy M, Ligor T, Amann A: Human exhaled air analytics: biomarkers of disease. Biomed Chromatogr. 2007, 21: 553-566. 10.1002/bmc.835.PubMedCrossRef Buszewski B, Kesy M, Ligor T, Amann A: Human exhaled air analytics: biomarkers of disease. Biomed Chromatogr. 2007, 21: 553-566. 10.1002/bmc.835.PubMedCrossRef
38.
go back to reference Vandendriessche T, Keulemans J, Geeraerd A, Nicolai BM, Hertog MLATM: Evaluation of fast volatile analysis for detection of botrytis cinerea infections in strawberry. Food Microbiol. 2012, 32: 406-14. 10.1016/j.fm.2012.08.002.PubMedCrossRef Vandendriessche T, Keulemans J, Geeraerd A, Nicolai BM, Hertog MLATM: Evaluation of fast volatile analysis for detection of botrytis cinerea infections in strawberry. Food Microbiol. 2012, 32: 406-14. 10.1016/j.fm.2012.08.002.PubMedCrossRef
39.
go back to reference Wang T, Pysanenko A, Dryahina K, Spaněl P, Smith D: Analysis of breath, exhaled via the mouth and nose, and the air in the oral cavity. J Breath Res. 2008, 2: 037013-10.1088/1752-7155/2/3/037013.PubMedCrossRef Wang T, Pysanenko A, Dryahina K, Spaněl P, Smith D: Analysis of breath, exhaled via the mouth and nose, and the air in the oral cavity. J Breath Res. 2008, 2: 037013-10.1088/1752-7155/2/3/037013.PubMedCrossRef
40.
go back to reference Hansen SK, Rau MH, Johansen HK, Ciofu O, Jelsbak L, Yang L, Folkesson A, Jarmer HØ, Aanæs K, von Buchwald C, Høiby N, Molin S: Evolution and diversification of pseudomonas aeruginosa in the paranasal sinuses of cystic fibrosis children have implications for chronic lung infection. ISME J. 2012, 6: 31-45. 10.1038/ismej.2011.83.PubMedPubMedCentralCrossRef Hansen SK, Rau MH, Johansen HK, Ciofu O, Jelsbak L, Yang L, Folkesson A, Jarmer HØ, Aanæs K, von Buchwald C, Høiby N, Molin S: Evolution and diversification of pseudomonas aeruginosa in the paranasal sinuses of cystic fibrosis children have implications for chronic lung infection. ISME J. 2012, 6: 31-45. 10.1038/ismej.2011.83.PubMedPubMedCentralCrossRef
Metadata
Title
Detection of Pseudomonas aeruginosa in sputum headspace through volatile organic compound analysis
Authors
Pieter C Goeminne
Thomas Vandendriessche
Johan Van Eldere
Bart M Nicolai
Maarten LATM Hertog
Lieven J Dupont
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2012
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-13-87

Other articles of this Issue 1/2012

Respiratory Research 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.